Cost-effectiveness of dolutegravir vs. efavirenz-based combined antiretroviral therapies in HIV-infected treatment-naive patients in a Nigerian treatment centre

BACKGROUND: Dolutegravir (DTG) based antiretroviral therapy (ART) has largely replaced Efavirenz (EFV) based therapy as the preferred first-line regimen in the treatment of adults with HIV. This study was carried out to evaluate the comparative cost-effectiveness of DTG and EFV-based ART in HIV-infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Isah, Abdulmuminu, Chukwu, Patrick O, Abba, Abubakar, Igboeli, Nneka U, Ebere, Ayogu, Omotola, Olusegun F, Alozie, Faith A, Ekwunife, Obinna I, Adibe, Maxwell O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398478/
https://www.ncbi.nlm.nih.gov/pubmed/37545946
http://dx.doi.org/10.4314/ahs.v23i1.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398478/
https://www.ncbi.nlm.nih.gov/pubmed/37545946
http://dx.doi.org/10.4314/ahs.v23i1.18

Ejemplares similares